The Microfluidic Devices Market is playing a growing role in oncology by enabling faster and more sensitive cancer diagnostics. Microfluidic technologies help detect circulating tumor cells, cancer biomarkers, and genetic mutations using extremely small biological samples. These capabilities support earlier diagnosis and improve treatment planning for patients.

Researchers are also using microfluidic platforms to develop personalized cancer therapies by studying how tumor cells respond to different medications. As precision oncology continues to expand, microfluidic technologies are expected to become increasingly valuable for both clinical diagnostics and pharmaceutical research.

FAQ

Q1. How do microfluidic devices help in cancer care?
They support early detection and biomarker analysis.

Q2. What samples are used?
Blood and other small biological samples.

Q3. Why is early diagnosis important?
It improves treatment outcomes and patient survival.